Opens in a new tab

Mathys & Squire v Astellas Institute for Regenerative Medicine (CFI, 4 November 2024)

Date4 November 2024
CourtCFI
DivisionMunich (DE) Central Division - Section
Type of actionApplication RoP262.3
Registry referenceApp_54214/2024 · ORD_55220/2024
PartiesMathys & Squire LLP

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 4 November 2024 (UPC_CFI_75/2023, ACT_464985/2023), the Munich Central Division (U. Voß, presiding, A. Kupecz, rapporteur, and P. Gerli, technically qualified judge), in the revocation action against EP 3 056 563 brought by Astellas Institute for Regenerative Medicine against Healios, Riken and Osaka University, granted Mathys & Squire, a non-party, access to the unredacted version of two pleadings (Reply of 29 November 2023 and Rejoinder of 29 December 2023). The order shows that redactions not justified in good time will not withstand an access request from a member of the public.

Question

Should information redacted by the claimant, concerning its product pipeline timeline and filed in support of its position on the value of the dispute, remain confidential vis-à-vis the third party seeking access?

Decision

Access to the pleadings had been granted on 22 August 2024 under Rule 262.1(b), but only redacted versions of the two documents were released. The application meets the formal requirements of Rule 262.4 and is admissible. Following the Court of Appeal in Ocado v Autostore, the Court weighs the applicant’s interest in access only against the party’s legitimate interest in confidentiality. Once the applicant credibly sets out its reasons, the party claiming confidentiality must rebut them with substantiation, an approach the Court applies by analogy with a Court of Appeal order on security for costs. The claimant did not show that the information remained confidential and, invited to comment by the preliminary order of 8 October 2024, added nothing, the defendants did not respond. The balance favours the third party, and the Registry is instructed to release the full versions.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 45
Rules of Procedure
Rules 262.1(b), 262.2, 262.3, 262.4, 262.5 and 262.6
Case law cited
Ocado Innovation v Autostore, Court of Appeal, 10 April 2024, Court of Appeal, 17 September 2024, UPC_CoA_217/2024 (security for costs), Astellas v Healios, Munich Central Division, 22 August 2024.

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Confidentiality club.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Application RoP262.3
Outcome (Dhenne Avocats summary)
Mathys & Squire obtient l'accès à la version non occultée de deux écritures, la demanderesse n'ayant pas étayé le caractère confidentiel des informations occultées.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 056 563
Method of producing retinal pigment epithelial cell
recorded proprietor: Healios KK, RIKEN et University of Osaka NUC
Mentioned in the analysis (role not qualified)
Also mentioned in 7 other decision(s): Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 Au · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 23 Ju · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 M · Mathys & Squire v Astellas (CFI, 28 December 2023) · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_C · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 Se · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.